These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30690188)

  • 1. On the unphysical hypotheses in pharmacokinetics and oral drug absorption: Time to utilize instantaneous rate coefficients instead of rate constants.
    Mavroudis PD; Kosmidis K; Macheras P
    Eur J Pharm Sci; 2019 Mar; 130():137-146. PubMed ID: 30690188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
    Macheras P; Iliadis A; Melagraki G
    Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutic classification of drugs revisited.
    Daousani C; Macheras P
    Eur J Pharm Sci; 2016 Dec; 95():82-87. PubMed ID: 27496048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant intake of alcohol may increase the absorption of poorly soluble drugs.
    Fagerberg JH; Sjögren E; Bergström CAS
    Eur J Pharm Sci; 2015 Jan; 67():12-20. PubMed ID: 25444841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Using Dogs to Predict Fraction of Oral Dose Absorbed in Humans for Poorly Water-Soluble Drugs.
    Matsumura N; Yamaura Y; Katagi J; Ono S; Kim S; Yamashita S; Sugano K
    J Pharm Sci; 2018 Sep; 107(9):2489-2496. PubMed ID: 29859956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS.
    Garrison KL; Sahin S; Benet LZ
    J Pharm Sci; 2015 Sep; 104(9):3229-35. PubMed ID: 26010239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing the Impact of Physiologically Based Oral Absorption Modeling and Simulation.
    Chung JI; Kelly RC; Wahlstrom J; Wu B; Wu T; Alvarez-Nunez F
    J Pharm Sci; 2017 Mar; 106(3):734-737. PubMed ID: 27915208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
    Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
    J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts.
    Kalampokis A; Argyrakis P; Macheras P
    Pharm Res; 1999 Nov; 16(11):1764-9. PubMed ID: 10571284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption.
    Kaur N; Narang A; Bansal AK
    Eur J Pharm Biopharm; 2018 Aug; 129():222-246. PubMed ID: 29879527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.
    Willmann S; Thelen K; Lippert J
    J Pharm Pharmacol; 2012 Jul; 64(7):997-1007. PubMed ID: 22686345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling heterogeneity of properties and random effects in drug dissolution.
    Lánský P; Weiss M
    Pharm Res; 2001 Jul; 18(7):1061-7. PubMed ID: 11496946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of human pharmacokinetics--gastrointestinal absorption.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption.
    Jakubiak P; Wagner B; Grimm HP; Petrig-Schaffland J; Schuler F; Alvarez-Sánchez R
    Mol Pharm; 2016 Feb; 13(2):586-98. PubMed ID: 26674605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.